Alex Fässler

Alex Fässler

Direttore operativo presso Targimmune Therapeutics AG

Patrimonio netto: 3 M $ in data 30/04/2024

69 anni
Health Technology
Consumer Services

Provenienza dei contatti di primo grado di Alex Fässler

EntitàTipo di entitàSettore Industriale
8
Holding Company Pharmaceuticals: Major 8

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Alex Fässler tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
ROCHE HOLDING AG Pharmaceuticals: Major

Andreas Emmenegger

Kuno Sommer

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Andreas Emmenegger

Kuno Sommer

Corporate Officer/Principal

Corporate Officer/Principal

KERYX BIOPHARMACEUTICALS Pharmaceuticals: Major

Peter Morgan Kash

Founder

Investment Banks/Brokers

Paolo Fundarò

Corporate Officer/Principal

INTERCEPT PHARMACEUTICALS, INC. Pharmaceuticals: Major

Peter Morgan Kash

Paolo Fundarò

Director/Board Member

Chairman

Pharmaceuticals: Major

Esteban Pombo-Villar

Chief Operating Officer

Miscellaneous Commercial Services

Paolo Fundarò

Corporate Officer/Principal

Investment Managers

Christoph Rentsch

Corporate Officer/Principal

TESSELLIS S.P.A. Major Telecommunications

Paolo Fundarò

Director/Board Member

BACHEM HOLDING AG Pharmaceuticals: Major

Kuno Sommer

Chairman

Hotels/Resorts/Cruise lines

Kuno Sommer

Chairman

Real Estate Development

Christoph Rentsch

Corporate Officer/Principal

SANTHERA PHARMACEUTICALS HOLDING AG Pharmaceuticals: Major

Christoph Rentsch

Director of Finance/CFO

Major Telecommunications

Paolo Fundarò

Corporate Officer/Principal

The Hebrew University of Jerusalem College/University

Alexander Levitzki

Corporate Officer/Principal

University of Basel College/University

Kuno Sommer

Doctorate Degree

University of Bocconi College/University

Paolo Fundarò

Undergraduate Degree

Swiss Federal Institute of Technology College/University

Esteban Pombo-Villar

Doctorate Degree

SPEXIS AG Pharmaceuticals: Major

Kuno Sommer

Christoph Rentsch

Director/Board Member

Director of Finance/CFO

Miscellaneous Commercial Services

Esteban Pombo-Villar

Corporate Officer/Principal

The Institute for Advanced Studies In Aging & Geriatric Medi

Alexander Levitzki

Director/Board Member

Biotechnology

Alexander Levitzki

Director/Board Member

Medical Specialties

Alexander Levitzki

Founder

ARNO THERAPEUTICS, INC. Pharmaceuticals: Major

Peter Morgan Kash

Founder

Investment Managers

Paolo Fundarò

Chief Executive Officer

Medical Specialties

Paolo Fundarò

Director/Board Member

Pharmaceuticals: Major

Kuno Sommer

Chairman

Miscellaneous Commercial Services

Kuno Sommer

Chief Executive Officer

Miscellaneous Commercial Services

Alexander Levitzki

Corporate Officer/Principal

Biotechnology

Paolo Fundarò

Chief Executive Officer

University of Applied Sciences Basel College/University

Christoph Rentsch

Undergraduate Degree

Ferienclub Privilège AG

Kuno Sommer

Director/Board Member

Alusuisse-Lonza America, Inc.

Christoph Rentsch

Director of Finance/CFO

Caperis Partners AG

Christoph Rentsch

Corporate Officer/Principal

Packaged Software

Paolo Fundarò

Director/Board Member

PDS Pathology Data Systems Co. Ag

Kuno Sommer

Chairman

Packaged Software

Paolo Fundarò

Director/Board Member

GENENTA SCIENCE S.P.A. Pharmaceuticals: Major

Paolo Fundarò

Director/Board Member

Motor Vehicles

Paolo Fundarò

Corporate Officer/Principal

Medical Specialties

Paolo Fundarò

Director/Board Member

Data Systems AG

Kuno Sommer

Chairman

Investment Managers

Paolo Fundarò

Founder

Biotechnology

Kuno Sommer

Chairman

Statistiche

Distribuzione geografica

Svizzera 19
Stati Uniti 14
Italia 12
Israele 7
Regno Unito 2

Settori

Health Technology 21
Consumer Services 8
Finance 7
Commercial Services 6
Communications 3

Posizioni

Director/Board Member 39
Corporate Officer/Principal 24
Chairman 11
Founder 10
Director of Finance/CFO 9
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA